Physician profile
Daniel Carducci
NPI 1669812731
$9,316.15
in general payments reported to CMS, 2019-2025
51 companies · $1,719 in 2025
The $1,719 reported for 2025 was more than what 89% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,800 · 2022: $2,050 · 2023: $1,834 · 2024: $1,914 · 2025: $1,719.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,376 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,376.26 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,738.38 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $1,122.87 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,106.20 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $854.43 | 2021-2025 | Xifaxan, Trulance |
| Lilly USA, LLC | $612.98 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $317.81 | 2021-2025 | |
| Glaxosmithkline, LLC. | $289.04 | 2021-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $269.73 | 2022-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $267.91 | 2021-2025 | Rexulti |
| Astellas Pharma US INC | $252.92 | 2023-2025 | Veozah, Myrbetriq |
| Antares Pharma, INC. | $204.16 | 2021-2024 | Xyosted, Nocdurna, Tlando |
| Takeda Pharmaceuticals U.S.A., INC. | $175.02 | 2021-2025 | Trintellix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $130.69 | 2021-2025 | Synjardy, Jardiance |
| Sanofi-Aventis U.S. LLC | $123.05 | 2021-2025 | |
| Exact Sciences Corporation | $119.98 | 2023-2025 | Cologuard Collection Kit |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $113.00 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $112.40 | 2021-2025 | Zoryve |
| Jazz Pharmaceuticals INC. | $112.02 | 2021-2022 | |
| Idorsia Pharmaceuticals US INC | $110.45 | 2023-2024 | Quviviq |
| Lundbeck LLC | $109.09 | 2021-2025 | Rexulti |
| Merck Sharp & Dohme LLC | $108.70 | 2021-2023 | Belsomra, Steglatro |
| Abbott Laboratories | $97.19 | 2023-2025 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $81.53 | 2022-2023 | |
| Daiichi Sankyo INC. | $77.93 | 2021-2022 | |
| Intuity Medical INC | $77.27 | 2022 | |
| Axsome Therapeutics, INC. | $66.99 | 2023-2025 | Auvelity, Sunosi |
| Neurocrine Biosciences, INC. | $57.57 | 2023 | Ingrezza |
| Biohaven Pharmaceutical Holding Company LTD. | $53.76 | 2022 | |
| Nevro Corp. | $53.27 | 2021-2022 | |
| Phathom Pharmaceuticals, INC. | $43.08 | 2024-2025 | Voquezna |
| Phadia US INC. | $42.43 | 2024 | Immunocap |
| Hologic Sales and Service, LLC | $36.40 | 2024-2025 | Aptima, Thinprep 2000 Processor |
| Inspire Medical Systems, INC. | $34.65 | 2024 | Inspire |
| Eisai INC. | $32.91 | 2024 | |
| Bausch Health US, LLC | $32.74 | 2022-2023 | Wellbutrin, Aplenzin |
| Insulet Corporation | $28.53 | 2025 | Omnipod |
| Seqirus USA INC | $27.02 | 2022-2025 | Fluad, Flucelvax |
| Ibsa Pharma INC. | $24.63 | 2021 | |
| Corium, LLC | $23.33 | 2025 | Azstarys |
| Kaleo, INC. | $17.77 | 2023 | Auvi-Q |
| Soleno Therapeutics, INC. | $17.08 | 2025 | Vykat Xr |
| Halozyme INC | $16.72 | 2023 | |
| Corcept Therapeutics | $14.95 | 2023 | Korlym |
| Genentech USA, INC. | $14.73 | 2021 | |
| Adlon Therapeutics L.P. | $13.63 | 2021 | |
| Amgen INC. | $13.48 | 2025 | Repatha |
| Amarin Pharma, INC. | $13.41 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $13.36 | 2023 | |
| Esperion Therapeutics, INC. | $13.35 | 2021 | |
| Acerus Pharmaceuticals Corporation | $13.32 | 2022 | |
| Medtronic, INC. | $12.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Carducci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.